Hypertension

Cardiovascular
234
Pipeline Programs
30
Companies
50
Clinical Trials
30
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
29
0
17
2
78
108
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
8799%
RNA Therapeutic
11%
+ 206 programs with unclassified modality

On Market (30)

Approved therapies currently available

Bayer
8-HOUR BAYERApproved
aspirin
Bayer
oral1965
U
ADALAT CCApproved
nifedipine
Unknown Company
oral1993
Pfizer
ALTACEApproved
ramipril
Pfizer
oral1991
U
ARBLIApproved
losartan potassium
Unknown Company
oral2025
Sanofi
AVAPROApproved
irbesartan
Sanofi
Angiotensin 2 Receptor Blocker [EPC]oral1997
Bayer
BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAINApproved
aspirin
Bayer
oral2001
U
BENICARApproved
olmesartan medoxomil
Unknown Company
oral2002
U
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDEApproved
candesartan cilexetil and hydrochlorothiazide
Unknown Company
Thiazide Diuretic [EPC]oral2012
U
CAROSPIRApproved
spironolactone
Unknown Company
Aldosterone Antagonist [EPC]oral2017
M&
COZAARApproved
losartan potassium
Merck & Co.
oral1995
Novartis
DIOVANApproved
valsartan
Novartis
Angiotensin 2 Receptor Blocker [EPC]oral2001
Novartis
DIOVAN HCTApproved
valsartan and hydrochlorothiazide
Novartis
Angiotensin 2 Receptor Blocker [EPC]oral1998
U
DURLAZAApproved
aspirin
Unknown Company
oral2015
U
ERTUGLIFLOZINApproved
ertugliflozin
Unknown Company
oral2023
Novartis
EXFORGEApproved
amlodipine besylate and valsartan
Novartis
Angiotensin 2 Receptor Blocker [EPC]oral2007
Novartis
EXFORGE HCTApproved
amlodipine valsartan and hydrochlorothiazide
Novartis
Angiotensin 2 Receptor Blocker [EPC]oral2009
U
IRBESARTANApproved
irbesartan
Unknown Company
oral2024
Recordati
ISTURISAApproved
osilodrostat
Recordati
oral2020
U
KAPSPARGO SPRINKLEApproved
metoprolol succinate
Unknown Company
oral2018
U
LOSARTAN POTASSIUMApproved
losartan potassium
Unknown Company
oral2010
Bayer
MEASURINApproved
aspirin
Bayer
oral1965
Boehringer Ingelheim
MICARDISApproved
telmisartan
Boehringer Ingelheim
Angiotensin 2 Receptor Blocker [EPC]oral1998
U
NIFEDIPINEApproved
nifedipine
Unknown Company
Dihydropyridine Calcium Channel Blocker [EPC]oral2019
U
NORLIQVAApproved
amlodipine
Unknown Company
Dihydropyridine Calcium Channel Blocker [EPC]oral2022
U
OLMESARTAN MEDOXOMILApproved
olmesartan medoxomil
Unknown Company
oral2019
M&
STEGLATROApproved
ertugliflozin
Merck & Co.
oral2017
U
TELMISARTAN AND AMLODIPINEApproved
telmisartan and amlodipine
Unknown Company
Angiotensin 2 Receptor Blocker [EPC]oral2014
U
TRANDOLAPRILApproved
trandolapril
Unknown Company
oral2008
U
VAZALOREApproved
aspirin
Unknown Company
oral2013
U
VOSTALLYApproved
ramipril
Unknown Company
Angiotensin Converting Enzyme Inhibitor [EPC]oral2025

Competitive Landscape

45 companies ranked by most advanced pipeline stage

Boehringer Ingelheim
Boehringer IngelheimINGELHEIM, Germany
108 programs
1
4
39
24
Frequent blood pressure measurementsPhase 41 trial
High dose of MICARDIS®, once dailyPhase 41 trial
High dose of Micardis®, once dailyPhase 41 trial
LacidipinePhase 4Small Molecule1 trial
Low dose of telmisartanPhase 4Small Molecule1 trial
+103 more programs
Active Trials
NCT01108796Completed1,856Est. Sep 2009
NCT00613314Completed15,268
NCT01853839Completed1,674Est. Jul 2014
+105 more trials
Novartis
NovartisBASEL, Switzerland
25 programs
1
3
11
5
AliskirenPhase 41 trial
Aliskiren HydrochlorothiazidePhase 41 trial
Aliskiren/AmlodipinePhase 4Small Molecule1 trial
EXFORGE(valsartan)Phase 4Small Molecule5 trials
valsartan, fluvastatinPhase 4Small Molecule1 trial
+20 more programs
Active Trials
NCT06683768Completed40,563Est. Nov 2023
NCT06899750Recruiting200Est. Oct 2026
NCT06643936Active Not Recruiting150Est. Apr 2026
+32 more trials
DS
22 programs
2
1
1
6
11
Olmesartan medoxomilPhase 41 trial
Olmesartan medoxomilPhase 41 trial
Olmesartan medoxomilPhase 41 trial
Olmesartan medoxomilPhase 41 trial
Perindopril + amlodipine + if necessary, hydrochlorothiazidePhase 41 trial
+17 more programs
Active Trials
NCT00834600Completed185Est. Oct 2011
NCT04019652Completed55Est. Dec 2015
NCT00151814Completed24Est. Feb 2008
+24 more trials
Pfizer
19 programs
2
3
8
Blood pressure measurementsPhase 41 trial
CaduetPhase 41 trial
ComputerPhase 41 trial
Doxazosin gastrointestinal therapeutic systemPhase 41 trial
RamiprilPhase 4Small Molecule1 trial
+14 more programs
Active Trials
NCT01260857Withdrawn0Est. Feb 2015
NCT00374829Unknown223Est. Jun 2007
NCT00229242Completed38Est. Mar 2007
+24 more trials
M&
Merck & Co.RAHWAY, NJ
12 programs
2
1
3
3
Amlodipine 10 mg or Losartan 100 mg + Amlodipine 5 mgPhase 41 trial
BisoprololPhase 4Small Molecule5 trials
ErtugliflozinPhase 4Small Molecule1 trial
L50/H12.5/A5Phase 31 trial
losartan potassiumPhase 33 trials
+7 more programs
Active Trials
NCT01643473Completed42Est. May 2018
NCT01074281CompletedEst. Aug 2009
+15 more trials
Takeda
12 programs
1
1
4
2
Candesartan cilexetil and hydrochlorothiazidePhase 41 trial
Manidipine 20mgPhase 41 trial
Azilsartan Medoxomil and amlodipinePhase 3Small Molecule1 trial
Azilsartan medoxomilPhase 31 trial
Azilsartan medoxomil and olmesartanPhase 3Small Molecule1 trial
+7 more programs
Active Trials
NCT02400775Withdrawn0Est. Apr 2016
NCT02181816Completed1,090Est. Jan 2017
NCT02079805Completed33Est. Apr 2016
+21 more trials
AstraZeneca
11 programs
2
1
2
1
metoprolol succinate prolonged-release tablet and felodipinePhase 4Small Molecule1 trial
metoprolol succinatePhase 31 trial
metoprolol succinatePhase 31 trial
CIN-107Phase 21 trial
CIN-107Phase 11 trial
+6 more programs
Active Trials
NCT00526279Completed9,000Est. Aug 2008
NCT02459990Completed22,000Est. Jun 2015
NCT02336607Completed529Est. Aug 2006
+8 more trials
Bayer
7 programs
5
24 hour blood pressure measurementPhase 41 trial
AspirinPhase 41 trial
NifedipinePhase 4Small Molecule1 trial
NifedipinePhase 4Small Molecule5 trials
Nifedipine GITSPhase 41 trial
+2 more programs
Active Trials
NCT01118286Completed4,497Est. Sep 2011
NCT01219556Completed8,704Est. Feb 2013
NCT00139984Completed170Est. May 2007
+8 more trials
Abbott
AbbottABBOTT PARK, IL
6 programs
4
AF Suppression Pacing AlgorithmPhase 41 trial
TrandolaprilPhase 4Small Molecule1 trial
Verapamil SR/Trandolapril/HydrochlorothiazidePhase 41 trial
trandolapril/verapamilPhase 43 trials
Canadian Study of Trandolapril on Blood Pressure in Hypertensive PatientsN/A1 trial
+1 more programs
Active Trials
NCT01078584Completed7,993Est. Sep 2011
NCT01903187Terminated4Est. Nov 2016
NCT00256152Completed2,580Est. Jun 2010
+5 more trials
Sanofi
5 programs
4
IrbesartanPhase 4Small Molecule1 trial
RamiprilPhase 4Small Molecule1 trial
Ramipril + FelodipinePhase 4Small Molecule1 trial
Ramipril-FelodipinePhase 4Small Molecule1 trial
RIAT Registry: Reason for Not Intensifying Antihypertensive TreatmentN/A1 trial
Active Trials
NCT00258921Completed31,870Est. Jul 2006
NCT00362258Completed797Est. Sep 2008
NCT00325806Completed1,008Est. Aug 2005
+2 more trials
Alliance Pharmaceuticals
1
InterventionPhase 41 trial
Educating participants about healthcare resourcesN/A1 trial
Enhanced Usual Care GroupN/A1 trial
Food Subsidy, 6 monthsN/A1 trial
Active Trials
NCT07136402Withdrawn0Est. May 2028
NCT04010344Completed240Est. Dec 2024
NCT05048836Completed525Est. Aug 2024
+1 more trials
Bristol Myers Squibb
4 programs
1
2
IrbesartanPhase 4Small Molecule
IrbesartanPhase 4Small Molecule
IrbesartanPhase 3Small Molecule
RIAT Registry: Reason for Not Intensifying Antihypertensive TreatmentN/A
LP
Lee's PharmaceuticalChina - Guangzhou
4 programs
1
1
2
ZanidipPhase 41 trial
stentPhase 41 trial
Azilsartan tabletsPhase 31 trial
20mg Azilsartan TabletsPhase 11 trial
Active Trials
NCT02786082Completed29Est. Nov 2017
NCT02609490Completed304Est. Aug 2018
NCT01520285Completed281Est. Aug 2013
+1 more trials
Closed Loop Medicine
2
AmlodipinePhase 4Small Molecule1 trial
AmlodipinePhase 4Small Molecule1 trial
ZestrilN/A1 trial
Active Trials
NCT06745726Not Yet RecruitingEst. Oct 2026
NCT04559074CompletedEst. Nov 2021
NCT06713785WithdrawnEst. May 2021
J&
Johnson & JohnsonNEW BRUNSWICK, NJ
2 programs
1
Anti-hypertensive therapyPhase 41 trial
Parish nurse visitN/A1 trial
Active Trials
NCT00535444Completed100Est. Oct 2007
NCT02299414Completed2,408Est. Dec 2022
Gedeon Richter
Gedeon RichterHungary - Budapest
2 programs
1
1
spironolactonePhase 41 trial
Azilsartan medoxomil 80 mg tabletPhase 11 trial
Active Trials
NCT06990204Not Yet Recruiting56Est. Jul 2025
NCT00524615Unknown160Est. Dec 2012
Arrowhead Pharmaceuticals
1 program
1
Anti-hypertensive therapyPhase 4
Recordati
RecordatiFrance - Saint-Victor
1 program
1
OsilodrostatPhase 4Small Molecule1 trial
Active Trials
NCT07247162Not Yet Recruiting63Est. Jul 2028
Alvogen
AlvogenNJ - Morristown
3 programs
1
2
DP-R208Phase 31 trial
DP-R212Phase 31 trial
AmlodipinePhase 1Small Molecule1 trial
Active Trials
NCT02789475Unknown38Est. Jul 2016
NCT02770261Completed219Est. Oct 2016
NCT02955368Withdrawn0Est. Aug 2017
City Therapeutics
City TherapeuticsMA - Cambridge
2 programs
1
Therapeutic Lifestyle ChangesPhase 31 trial
New York City (NYC) Health eHearts Pay for Quality PilotN/A1 trial
Active Trials
NCT00884013Completed
NCT01070056CompletedEst. Jul 2012
Genomics
2 programs
1
1
FiribastatPhase 3Small Molecule1 trial
QGC001Phase 21 trial
Active Trials
NCT03198793Completed256Est. Nov 2018
NCT04277884Completed515Est. Sep 2022
GS
Gilead SciencesFOSTER CITY, CA
2 programs
2
DarusentanPhase 34 trials
DarusentanPhase 31 trial
Active Trials
NCT00353574Terminated282Est. Apr 2010
NCT00389779Completed849Est. Aug 2009
NCT00330369Completed352Est. Jan 2009
+2 more trials
LB
Lepu BiopharmaChina - Shanghai
1 program
1
LEPU Renal Denervation SystemPhase 31 trial
Active Trials
NCT02536326CompletedEst. May 2015
Mineralys Therapeutics
1 program
1
lorundrostatPhase 3Small Molecule1 trial
Active Trials
NCT05968430Active Not Recruiting1,076Est. Dec 2026
Alnylam Pharmaceuticals
2 programs
1
1
IndapamidePhase 21 trial
ALN-AGT01Phase 11 trial
Active Trials
NCT03934307Completed124Est. Jan 2023
NCT05103332Completed663Est. Sep 2024
BioMarin Pharmaceutical
1
6R-BH4Phase 21 trial
Active Trials
NCT00325962Completed84Est. Dec 2008
Ionis Pharmaceuticals
1 program
1
ION904Phase 21 trial
Active Trials
NCT05314439Completed48Est. Feb 2023
Palatin Technologies
1 program
1
PL3994Phase 21 trial
Active Trials
NCT00686803CompletedEst. Jul 2008
Kardigan
KardiganCA - South SF
1 program
1
TonlamarsenPhase 2RNA Therapeutic1 trial
Active Trials
NCT06864104Active Not Recruiting206Est. Mar 2026
VP
1
iloperidonePhase 21 trial
Active Trials
NCT07090161Recruiting240Est. Nov 2026

+15 more companies

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
RecordatiOsilodrostat
Closed Loop MedicineAmlodipine
Closed Loop MedicineAmlodipine
Merck & Co.Ertugliflozin
Merck & Co.Bisoprolol
BayerNifedipine GITS
BayerNifedipine
BayerNifedipine
TakedaManidipine 20mg
TakedaAzilsartan medoxomil
Johnson & JohnsonAnti-hypertensive therapy
BayerNifedipine
TakedaAzilsartan
Alliance PharmaceuticalsIntervention
TakedaAzilsartan

Showing 15 of 50 trials with date data

Clinical Trials (50)

Total enrollment: 19,210 patients across 50 trials

Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome

Start: Aug 2026Est. completion: Jul 202863 patients
Phase 4Not Yet Recruiting

Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension

Start: Oct 2020Est. completion: Nov 2021
Phase 4Completed

Personalised Electronic Record Supported Optimisation of Amlodipine for Patients With Hypertension

Start: Sep 2020Est. completion: May 2021
Phase 4Withdrawn

Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes.

Start: Sep 2018Est. completion: Aug 20200
Phase 4Withdrawn

Efficacy of Oral Bisoprolol on Heart Rate Reduction in Chinese Chronic Heart Failure Participants

Start: Mar 2017Est. completion: Dec 2018
Phase 4Terminated
NCT02940548BayerNifedipine GITS

Nifedipine GITS and Amlodipine Besylate on Recovery of Blood Pressure Rhythm and Arterial Stiffness

Start: Dec 2016Est. completion: Dec 202099 patients
Phase 4Terminated

Effect of Nifedipine GITS in Patients With Mild-to-moderate Primary Hypertension

Start: Oct 2015Est. completion: Dec 2019700 patients
Phase 4Unknown

REducing Blood Pressure Variability in Essential Hypertension With RAmipril vErsus Nifedipine GITS Trial

Start: Oct 2015Est. completion: Nov 2020168 patients
Phase 4Completed
NCT03106597TakedaManidipine 20mg

Manidipine Versus Amlodipine in Patients With Hypertension

Start: Aug 2015Est. completion: Aug 201946 patients
Phase 4Terminated
NCT02517866TakedaAzilsartan medoxomil

Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia

Start: Jul 2015Est. completion: Nov 2016380 patients
Phase 4Completed
NCT02299414Johnson & JohnsonAnti-hypertensive therapy

Chronic Hypertension and Pregnancy (CHAP) Project

Start: Jun 2015Est. completion: Dec 20222,408 patients
Phase 4Completed

Blood Pressure Control of Nifedipine GITS 60mg Treatment in Chinese Hypertensive Subjects Uncontrolled on Starting-dose Mono-therapyo-therapy.

Start: Mar 2015Est. completion: Aug 2016278 patients
Phase 4Completed

A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.

Start: Mar 2015Est. completion: Apr 20160
Phase 4Withdrawn

Heart Outcomes Prevention and Evaluation 4

Start: Aug 2014Est. completion: Feb 20191,438 patients
Phase 4Completed

A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R

Start: Jun 2014Est. completion: Apr 201633 patients
Phase 4Completed

Study of Efficacy and Safety of CVAA489 in Hypertensive Patients

Start: Feb 2014Est. completion: Sep 2015115 patients
Phase 4Completed

The Effects of Eplerenone on Markers of Myocardial Fibrosis in Adult Congenital Heart Disease

Start: Aug 2013Est. completion: Jun 201626 patients
Phase 4Terminated

Comparision of Blood Pressure Variability Between Amlodipine and Losartan

Start: Apr 2013Est. completion: May 2017144 patients
Phase 4Completed

8-week Randomized, Open-label Study to Evaluate Food Effect on Efficacy and Safety of Oral Aliskiren 300 mg in Patients With Hypertension

Start: Apr 2012Est. completion: Nov 2012589 patients
Phase 4Completed

Comparison of Bisoprolol With Metoprolol Succinate Sustained-release on Heart Rate and Blood Pressure in Hypertensive Patients

Start: Dec 2011Est. completion: Apr 2014
Phase 4Completed

Compare the Effects of Lercanidipine Hydrochloride Tablet (Zanidip®) and Felodipine Sustained-Release Tablet for Hypertension

Start: Dec 2011Est. completion: Aug 2013281 patients
Phase 4Completed

Zainidip in Renal Artery Stenosis

Start: Sep 2011Est. completion: May 2014149 patients
Phase 4Completed

Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes

Start: May 2011Est. completion: Feb 2012975 patients
Phase 4Terminated

A Randomized Controlled Study to Assess the Effects of Bisoprolol and Atenolol on Resting Heart Rate and Sympathetic Nervous System's Activity in Subjects With Essential Hypertension

Start: Nov 2010Est. completion: Feb 2012
Phase 4Completed

Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients

Start: May 2010Est. completion: Apr 2011564 patients
Phase 4Completed

Phase 4 Study to Assess the Effect of Bisoprolol on Glycemic Level in Type II Diabetic Subjects With Suboptimal Blood Pressure Control

Start: Apr 2010Est. completion: Apr 2013202 patients
Phase 4Completed

Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPM

Start: Apr 2010Est. completion: Sep 201468 patients
Phase 4Completed
NCT01101009Daiichi SankyoPerindopril + amlodipine + if necessary, hydrochlorothiazide

Comparison of Sevikar® and the Combination of Perindopril/Amlodipine on Central Blood Pressure

Start: Apr 2010Est. completion: Dec 2012486 patients
Phase 4Completed

Low-dose Nifedipine-Valsartan Combination Compared to Up-titrated Valsartan Monotherapy in Essential Hypertension

Start: Feb 2010Est. completion: May 2011360 patients
Phase 4Completed

FOCUS (Nifedipine GITS's Effect on Central Pressure Assessed by Applanation Tonometry)

Start: Jan 2010Est. completion: Feb 2012365 patients
Phase 4Completed

A 12-week, Multicentric Study to Evaluate the Safety and Efficacy of Bisoprolol in Filipino Hypertensive Subjects With Diabetes

Start: Dec 2009Est. completion: Dec 2011
Phase 4Completed

An Active-controlled, Clinical Trial to Assess Central Hemodynamic Effects of Bisoprolol in Hypertensive Patients (Central Hemodynamic Assessment Measured in Patient With HypertensION [CHAMPION])

Start: Dec 2009Est. completion: Oct 2011209 patients
Phase 4Completed

A Prospective, Open-labeled, Multi-centric Trial in Subjects With Systolic Heart Failure to Evaluate Bisoprolol Treatment for the Effects on Surrogate Markers of Heart Failure in Korea

Start: Oct 2009Est. completion: Aug 2012
Phase 4Completed
NCT01012479TakedaCandesartan cilexetil and hydrochlorothiazide

Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe Hypertension

Start: Oct 2009Est. completion: Jun 2010107 patients
Phase 4Completed
NCT00949884Daiichi Sankyoolmesartan medoxomil

Olmesartan Comparison to Losartan in Hypertensive Subjects

Start: Aug 2009Est. completion: Jan 2010941 patients
Phase 4Completed

Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension

Start: Jul 2009Est. completion: Jan 2010488 patients
Phase 4Completed

Valsartan Intensified Primary Care Reduction of Blood Pressure Study

Start: Jul 2009Est. completion: Jul 20112,337 patients
Phase 4Completed

To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone

Start: Jun 2009Est. completion: Sep 201060 patients
Phase 4Completed

Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe Hypertension

Start: Jun 2009894 patients
Phase 4Completed
NCT00853957NovartisAliskiren/Amlodipine

Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension

Start: Feb 2009Est. completion: Aug 2009443 patients
Phase 4Completed
NCT00841880SanofiRamipril + Felodipine

China Medical University Hospital (CMUH) Triapin Listing

Start: Jan 2009Est. completion: Sep 200949 patients
Phase 4Completed

Association Between Genetic Polymorphism of Beta-adrenergic Receptor and Effects of Bisoprolol in Korean Heart Failure Patients.

Start: Dec 2008Est. completion: Jul 2010
Phase 4Completed
NCT00791258Daiichi Sankyoamlodipine and olmesartan medoxomil tablets

A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure

Start: Nov 2008Est. completion: Sep 2009999 patients
Phase 4Completed

Eplerenone in Systemic Right Ventricle

Start: Jul 2008Est. completion: Dec 201026 patients
Phase 4Completed
NCT00739596NovartisAliskiren Hydrochlorothiazide

Blood Pressure Lowering of Aliskiren Hydrochlorothiazide (HCTZ) Versus Amlodipine in Stage 2 Hypertension in African Americans

Start: Jul 2008Est. completion: Mar 2009332 patients
Phase 4Completed

Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.

Start: Apr 2008Est. completion: Jun 2009384 patients
Phase 4Completed

The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy

Start: Mar 2008728 patients
Phase 4Completed

Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg

Start: Jan 2008Est. completion: Jan 2009393 patients
Phase 4Completed

Efficacy of a Combination of Amlodipine/Valsartan on 24H Blood Pressure Control With One Nocturnal or Diurnal Intake a Day

Start: Oct 2007Est. completion: Aug 2008478 patients
Phase 4Completed

Study Evaluating the Efficacy of Nifedipine GITS - Telmisartan Combination in Blood Pressure Control.

Start: Oct 2007Est. completion: Aug 2009405 patients
Phase 4Completed

Related Jobs in Cardiovascular

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

78 late-stage (Phase 3) programs — potential near-term approvals
30 companies competing in this space